CERSCerus Corporation

$335M

Q3 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$36M+53.1% YoY

Gross Profit

$19M51.3% margin

Operating Income

-$11M-30.8% margin

Net Income

-$12M-34.4% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+14.8%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$219M

Total Liabilities

$138M

Stockholders' Equity

$80M

Cash & Equivalents

$78M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$24M	+53.1%
Gross Profit	$19M	$13M	+46.6%
Operating Income	-$11M	-$14M	+20.4%
Net Income	-$12M	-$14M	+12.0%

Revenue Segments

Government Contract

$6M100%

Geographic Segments

North America

$21M58%

Europe Middle East And Africa

$15M41%

Other

$306,0001%

CERS Q3 2021 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena